Streetbeat News

MRMD

MariMed Inc

Employees

326

Industry

Medicinal and Botanical Manufacturing

Open

0.16

Mkt cap

59M

Volume

18K

High

0.16

P/E Ratio

-5.17

52-wk high

0.39

Low

0.15

Div yield

N/A

52-wk low

0.14

Cannabis stocks have experienced a significant surge in early 2024, with the US cannabis MSOS ETF and the global YOLO ETF posting substantial gains. The uptick is attributed to the potential reclassification of cannabis by the DEA, following a recommendation from the Dept. of Health and Human Services. Companies like Jushi, The Cannabist, Cresco, and AYR have seen remarkable increases in their stock prices. Green Thumb Industries, Verano, and MariMed also enjoyed gains, albeit more modest. Agrify reported a notable improvement in financials, with a decrease in operating expenses contributing to a shift from a gross loss to a gain.

Portfolio Pulse from Nicolás Jose Rodriguez

January 09, 2024 | 8:49 pm

Viridian Capital Advisors highlighted five attractively priced cannabis stocks with solid credit rankings and potential for growth. The MSOS ETF saw a significant rise, attributed to DEA's consideration of rescheduling cannabis. Viridian is cautious about the timing of regulatory changes before the election. The selected stocks are Marimed (MRMD), Trulieve (TCNNF), Cresco (CRLBF), Verano (VRNOF), and Planet 13 (PLNH), chosen for their low EV/EBITDA multiples and resilience. Grown Rogue (GRIN), Glass House Brands (GLASF), and Curaleaf (CURLF) were considered overvalued, while Green Thumb (GTBIF) and TerrAscend (TSNDF) were excluded from the top picks.

Portfolio Pulse from Viridian Capital Advisors

January 08, 2024 | 4:57 pm

Cannabis stocks experienced significant movements on January 4, 2024. EVIO led the gainers with a 4900% increase, while AusCann Group Holdings saw the largest decline, dropping 37.98%. Other notable gainers include Khiron Life Sciences and Cannabix Technologies. Among the losers, Psychemedics and Global Compliance also saw substantial drops in their share prices.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 9:30 pm

The cannabis sector experienced significant movement on January 3, 2024, with a majority of stocks closing higher. Notable gainers included Affinor Growers, Khiron Life Sciences, and CLS Holdings USA, with increases of 74.05%, 66.67%, and 19.40% respectively. Eastside Distilling, Neptune Wellness Solutions, Cara Therapeutics, Genetic Technologies, Village Farms International, Green Thumb Industries, Mexco Energy, and Tilray Brands also saw gains. However, there were some losers, with 1933 Industries, Maple Leaf Green World, Global Compliance, Zoned Properties, and Psychemedics experiencing declines. Scotts Miracle Gro, Corbus Pharmaceuticals, Innovative Industrial Properties, MedMen Enterprises, ESCO Technologies, Item 9 Labs, and EnWave closed lower as well.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 9:30 pm

The cannabis industry saw significant leadership changes in 2023, with new CEOs appointed at various companies, including Humble & Fume Inc., WeedTube, MariMed, Unrivaled Brands, iAnthus Capital Holdings, PharmaCielo Ltd., MedMen Enterprises, Flora Growth Corp., Charlotte's Web, RX Green Technologies, AFC Gamma, Inc., Société québécoise du cannabis, The Blinc Group, and Kaival Brands Innovations Group. These changes are part of the industry's efforts to drive growth, sustainability, and social responsibility. Analysts are optimistic about the sector's potential for growth, with some stocks already showing substantial gains.

Portfolio Pulse from Jelena Martinovic

December 29, 2023 | 6:15 pm

On December 28, 2023, several cannabis stocks experienced significant price movements. Notable gainers included GrowLife, Rhinomed, AusCann Group Holdings, Khiron Life Sciences, and Cara Therapeutics, with GrowLife leading the surge with a 200% increase. On the losing end, The Flowr Corporation saw a dramatic 99.99% decline. Other decliners included CordovaCann, Rocky Mountain High, and Item 9 Labs. The cannabis sector showed high volatility with these sharp price changes.

Portfolio Pulse from Benzinga Insights

December 28, 2023 | 9:30 pm

MariMed Inc. and Acreage Holdings, Inc. have launched new cannabis products for the holiday season. MariMed's Betty's Eddies brand celebrates its 10th anniversary with Betty's Bubbly, a sparkling champagne chew with THC and THCV, available in Massachusetts, Maryland, and Delaware. Acreage Holdings introduces The Botanist THC-infused gummies in New York, with three different ratios of THC and CBD, expanding their product offerings in the state. Other companies like OGeez!, Good Day Farm, and The Hemp Doctor also released new cannabis products, while JARS Cannabis in Michigan promotes a '12 Days of Giveaways' event.

Portfolio Pulse from Joana Scopel

December 22, 2023 | 7:28 pm

Marijuana stocks experienced significant movement on Tuesday, with several companies seeing notable gains, while others faced declines. EVIO and GreenGro Technologies were among the top gainers, with shares closing up 9900.00% at $0.0001. Other gainers included iAnthus Capital Holdings, Maple Leaf Green World, Leafbuyer Technologies, GrowGeneration, Global Hemp Group, Neptune Wellness Solutions, Kaya Holdings, CordovaCann, Greenlane Holdings, Khiron Life Sciences, Pharmadrug, CNBX Pharmaceuticals, Scotts Miracle-Gro, 22nd Century Group, RIV Capital, Canopy Growth, Nextleaf Solutions, and Tilray Brands. On the losing side, MJ Holdings led the declines, followed by Target Group, SOL Global Investments, CLS Holdings USA, Heritage Cannabis Holding, Eastside Distilling, 1933 Industries, C21 Investments, Item 9 Labs, Rocky Mountain High, MariMed, Affinor Growers, Elixinol Wellness, Cannabix Technologies, and Blueberries Medical.

Portfolio Pulse from Benzinga Insights

December 19, 2023 | 9:30 pm

The Viridian Chart of the Week analyzed stock prices of leaders in various cannabis sectors relative to their 52-week highs and lows. Agriculture Technology is at a median of 131% of its 52-week lows, while Cultivation is at 159%, with companies like MariMed and AYR showing significant recovery. Psychedelics sector is up 158% from its lows with less volatility. Financial services show the lowest median recovery but are closest to their 52-week highs. The beer industry, used for comparison, shows lower volatility and higher average EV/EBITDA ratios than cannabis. The analysis suggests cautious optimism in the cannabis sector, with companies trading at less than 75% premiums to their 52-week lows, indicating a more measured investor approach to regulatory or legislative reform risks.

Portfolio Pulse from Viridian Capital Advisors

December 18, 2023 | 4:43 pm

On December 12, 2023, several cannabis stocks experienced significant price movements. Mojave Brands, GrowLife, and Affinor Growers were among the top gainers, with Mojave Brands closing up over 101 million percent. Conversely, Choom Holdings and EVIO were among the top losers, both closing down 99%. Notable US-listed companies that saw price changes include Urban-gro, Corbus Pharmaceuticals, Cara Therapeutics, GrowGeneration, Canopy Growth, OrganiGram Holdings, Greenlane Holdings, and Aurora Cannabis.

Portfolio Pulse from Benzinga Insights

December 12, 2023 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.